Evidence map›Paper›PMID 25252956›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Complement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3.

Rada Ellegård, Elisa Crisci, Adam Burgener, Christopher Sjöwall, Kenzie Birse, Garrett Westmacott, Jorma Hinkula, Jeffrey D Lifson, Marie Larsson

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. The role of the complement system in HIV infection and preeclampsia.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Rada EllegårdDivision of Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University, 581 85 Linköping, Sweden;
Elisa CrisciDivision of Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University, 581 85 Linköping, Sweden;
Adam BurgenerDepartment of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada;
Christopher SjöwallDivision of Rheumatology/Autoimmunity and Immune Regulation Unit, Department of Clinical and Experimental Medicine, Linköping University, 581 85 Linköping, Sweden; and.
Kenzie BirseDepartment of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba R3E 0J9, Canada; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada;
Garrett WestmacottNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada;
Jorma HinkulaDivision of Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University, 581 85 Linköping, Sweden;
Jeffrey D LifsonLeidos Biomedical Research, Inc., Frederick National Laboratory, Frederick, MD 21702.
Marie LarssonDivision of Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University, 581 85 Linköping, Sweden; marie.larsson@liu.se.
Linköping University · SEUniversity of Manitoba · CALeidos Biomedical Research Inc. (United States)Public Health Agency of Canada · CA

Funding

CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

Immature dendritic cells (iDCs) in genital and rectal mucosa may be one of the first cells to come into contact with HIV-1 during sexual transmission of virus. HIV-1 activates the host complement system, which results in opsonization of virus by inactivated complement fragments, for example, iC3b. We investigated antiviral and inflammatory responses induced in human iDCs after exposure to free HIV-1 (F-HIV), complement-opsonized HIV-1 (C-HIV), and complement and Ab-opsonized HIV-1 (CI-HIV). F-HIV gave rise to a significantly higher expression of antiviral factors such as IFN-β, myxovirus resistance protein A, and IFN-stimulated genes, compared with C-HIV and CI-HIV. Additionally, F-HIV induced inflammatory factors such as IL-1β, IL-6, and TNF-α, whereas these responses were weakened or absent after C-HIV or CI-HIV exposure. The responses induced by F-HIV were TLR8-dependent with subsequent activation of IFN regulatory factor 1, p38, ERK, PI3K, and NF-κB pathways, whereas these responses were not induced by C-HIV, which instead induced activation of IFN regulatory factor 3 and Lyn. This modulation of TLR8 signaling was mediated by complement receptor 3 and led to enhanced infection. The impact that viral hijacking of the complement system has on iDC function could be an important immune evasion mechanism used by HIV-1 to establish infection in the host.

Indexed as

Complement System ProteinsDendritic CellsExtracellular Signal-Regulated MAP KinasesGene Expression ProfilingHIV-1HIV InfectionsHumansImmunity, InnateInflammationInterferon Regulatory Factor-1Interferon Regulatory Factor-3Macrophage-1 AntigenModels, BiologicalNF-kappa Bp38 Mitogen-Activated Protein KinasesPhosphoinositide-3 Kinase InhibitorsComplement System ProteinsExtracellular Signal-Regulated MAP KinasesInterferon Regulatory Factor-1Interferon Regulatory Factor-3lyn protein-tyrosine kinaseMacrophage-1 AntigenNF-kappa Bp38 Mitogen-Activated Protein KinasesPhosphoinositide-3 Kinase InhibitorsRNA, Messengersrc-Family KinasesToll-Like Receptor 8

Identifiers

PMID25252956
PMCPMC4201991
OpenAlexW2118838697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.